Cargando…

Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage

Fertility preservation is an emerging discipline, which is of substantial clinical value in the care of young patients with cancer. Chemotherapy and radiation may induce ovarian damage in prepubertal girls and young women. Although many studies have explored the mechanisms implicated in ovarian toxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seongmin, Kim, Sung-Woo, Han, Soo-Jin, Lee, Sanghoon, Park, Hyun-Tae, Song, Jae-Yun, Kim, Tak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305189/ https://www.ncbi.nlm.nih.gov/pubmed/34299104 http://dx.doi.org/10.3390/ijms22147484

Ejemplares similares

Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation
por: Kim, Seongmin, et al.
Publicado: (2021)

Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity
por: Cho, Hyun-Woong, et al.
Publicado: (2020)

The Effectiveness of Anti-Apoptotic Agents to Preserve Primordial Follicles and Prevent Tissue Damage during Ovarian Tissue Cryopreservation and Xenotransplantation
por: Lee, Sanghoon, et al.
Publicado: (2021)

A Randomized, Multicenter, Double-Blind, Parallel, Non-Inferiority Clinical Study to Compare the Efficacy and Safety of Unicenta and Melsmon for Menopausal Symptom Improvement
por: Kim, Seongmin, et al.
Publicado: (2023)

Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation
por: Kim, Jeong Min, et al.
Publicado: (2021)

The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage
por: Sonigo, Charlotte, et al.
Publicado: (2019)

A Rare Case Report of Successful Laparoscopy-Guided Reduction of Non-Puerperal Uterine Inversion
por: Kim, Seongmin, et al.
Publicado: (2023)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2020)

The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery
por: Wong, Queenie Ho Yan, et al.
Publicado: (2018)

Ovarian tissue cryopreservation and transplantation in patients with cancer
por: Kim, Sooyoung, et al.
Publicado: (2018)

Role of Artificial Intelligence Interpretation of Colposcopic Images in Cervical Cancer Screening
por: Kim, Seongmin, et al.
Publicado: (2022)

Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer
por: Kim, Dong-Yun, et al.
Publicado: (2019)

Role of Klotho as a Modulator of Oxidative Stress Associated with Ovarian Tissue Cryopreservation
por: Kim, Boram, et al.
Publicado: (2021)

Changes in telomere length and senescence markers during human ovarian tissue cryopreservation
por: Kim, Boram, et al.
Publicado: (2021)

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
por: Kim, Hyun-Ah, et al.
Publicado: (2018)

Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018)

Overexpression of HER2/HER3 and clinical feature of ovarian cancer
por: Chung, Ye Won, et al.
Publicado: (2019)

Role of prognostic nutritional index in postoperative radiotherapy for non‐small cell lung cancer
por: Ryu, Hyejo, et al.
Publicado: (2023)

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
por: Lee, Yong Jae, et al.
Publicado: (2018)

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
por: Lee, Jung-Yun, et al.
Publicado: (2017)

Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
por: Chung, Young Shin, et al.
Publicado: (2018)

Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer
por: Kim, Seongmin, et al.
Publicado: (2019)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
por: Woo, Seon Rang, et al.
Publicado: (2014)

Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis
por: Kim, Seongmin, et al.
Publicado: (2023)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Comparison between Slow Freezing and Vitrification for Human Ovarian Tissue Cryopreservation and Xenotransplantation
por: Lee, Sanghoon, et al.
Publicado: (2019)

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study
por: Park, Jongha, et al.
Publicado: (2009)

Endoscopic findings of rectal mucosal damage after pelvic radiotherapy for cervical carcinoma: correlation of rectal mucosal damage with radiation dose and clinical symptoms
por: Kim, Tae Gyu, et al.
Publicado: (2013)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2014)

Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Lee, Yong Jae, et al.
Publicado: (2020)

Sarcoidosis Mimicking Cancer Metastasis Following Chemotherapy for Ovarian Cancer
por: Kim, Mi Hyun, et al.
Publicado: (2013)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
por: Kim, Yoo-Na, et al.
Publicado: (2019)

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study
por: Woo, Sang Myung, et al.
Publicado: (2017)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy
por: Jung, Wonguen, et al.
Publicado: (2021)

Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
por: Lee, Yong Jae, et al.
Publicado: (2018)

The comparison of surgical outcomes and learning curves of radical hysterectomy by laparoscopy and robotic system for cervical cancer: an experience of a single surgeon
por: Heo, Yoon Jung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j3ade59605etb977c545v06vjm